Abstract:49 Objectives: Patients with cardiac amyloidosis (CA), especially those with amyloid light-chain type (AL-CA), have a poor prognosis. The diagnosis of CA is often in advanced disease stage due to the non-specific clinical symptoms. Unfortunately, the treatment options are limited by then1. Therefore, early detection and accurate diagnosis plays an important role on the AL-CA patient management. Dynamic analysis of PET has attracted wide attention in recent years. By tracking the specific binding process of drugs and target, more accurate and specific pathological manifestations can be obtained. The aim of this study is to investigate the diagnosis performance of dynamic 11C-Pittsburgh B (11C-PIB) PET/CT on AL-CA. Methods: Twenty-one patients (age, 59.4±7.9 years; M/F, 12/9) with biopsy-proven diagnoses of AL-CA were enrolled. Seven subjects (age, 55.7±8.7 years; M/F, 4/3) who had neither history nor symptoms of cardiovascular diseases were recruited as healthy control. All subjects underwent a 30-min 11C-PIB PET/CT dynamic scan (SinoUnion PoleStar m660, China) with a dose of 411.1±89.7 MBq. Static images as early, intermediate and late scan at 5, 15, 25 min after radiotracer injection were reconstructed retrospectively. The left atrium blood pool volume of interest (VOI) was manually delineated by an experienced physician on MIM workstation (MIM Software Inc, USA). The left ventricular myocardium VOI and the left ventricle blood pool VOI were auto-segmented and manually calibrated to calculate kinetic parameters K1-k4 and metabolic rate constant Ki of the two-compartment model using Carimas software (Turku PET Centre, Finland, version 2.10)2. The retention index (RI) derived from the time-activity curve (TAC) was defined as the mean standardized uptake value (SUV) of the myocardial VOI from 10 to 20 min divided by the integral of the mean SUV of the left atrium blood pool VOI from 0 to 15 min. Semiquantitative analysis was performed on the static images at different time points. The standardized uptake value ratio (SUVR) was defined as the mean SUV of the myocardial VOI divided by the mean SUV of the left atrial blood pool VOI. Statistical analysis was performed between AL-CA and control groups. P < 0.05 was considered as significant. Results: The representative 11C-PIB PET/CT images at different static periods were shown in Figure 1. Patient case demonstrated higher SUV and slower wash-out process comparing with the control case, which can be observed by 11C-PIB PET/CT images as well as the corresponding TACs in Figure 2. SUVR in patients were significantly higher than that in controls over the whole acquisition period (early SUVR: 5.64±2.56 vs. 2.40±0.63; intermediate SUVR: 4.96±2.76 vs. 1.43±0.23; late SUVR: 4.56±2.67 vs. 1.34±0.22; with P < 0.001). Dynamic analysis (Figure 3) showed that K1, k2 and RI were significant different between AL-CA group and controls (4.96±1.08 vs. 5.82±0.56, 2.36±0.33 vs. 2.69±0.18, 0.04±0.01 vs. 0.14±0.08, with P=0.023, P=0.002, P<0.0001, respectively). Receiver operating characteristic curve (ROC) of RI on differentiating AL-CA group from controls yielded the sensitivity and specificity both 100% with the cutoff value of 0.515. ROCs of SUVR from intermediate and late static images on differentiating AL-CA group from controls presented the same sensitivity (95.2%) and specificity (100%) when the cutoff values were 1.835 and 1.695 (Table 1). Initial results showed that the kinetic parameters were effective to differentiate AL-CA patients from controls. The significant difference can also be observed by RI, which indicated that RI is an important clinical indicator for the diagnosis of AL-CA. Higher sensitivity of SUVR in the intermediate and late period of dynamic imaging indicated that dynamic imaging is valuable. Conclusions: 11C-PIB PET/CT dynamic imaging may represent a promising noninvasive tool for the early diagnosis of AL-CA. Big cohort study was needed for further investigation.

Kinetic Analysis of Cardiac Dynamic 18F-Florbetapir PET in Healthy Volunteers and Amyloidosis Patients: A Pilot Study

Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment

Dynamic analysis of 11C-PIB PET/CT in amyloid light-chain cardiac amyloidosis

18F-Florbetaben PET/CT for the Diagnosis and Subtyping of Cardiac Amyloidosis: A Case Series and Review of the Literature

Multiparametric Cardiac 18F-FDG PET: Pilot Comparison of FDG Delivery Rate with 82Rb Myocardial Blood Flow

A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al18F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease

The Image Quality, Amyloid-Β Detectability, and Acquisition Time of Clinical Florbetapir Positron Emission Tomography in Alzheimer's Disease and Healthy Adults.

Head-to-head comparison of [18F]florbetapir and [18F]FDG PET for the early detection of amyloidosis in systemic amyloidosis and plasma cell dyscrasias

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET

Measurement of Cerebral Perfusion Indices from the Early Phase of [18F]MK6240 Dynamic Tau PET Imaging

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease

Multiparametric Cardiac 18F-FDG PET in Humans: Kinetic Model Selection and Identifiability Analysis

Short-time Total-Body Dynamic PET Imaging Performance in Quantifying the Kinetic Metrics of 18F-FDG in Healthy Volunteers.

Design of a Short Nonuniform Acquisition Protocol for Quantitative Analysis in Dynamic Cardiac SPECT Imaging - a Retrospective 123 I-MIBG Animal Study.

P1‐155: Amyloid PET Imaging Using AZD4694 and Unusually Brief Radiotracer Uptake and Scanning Periods

IC‐P‐011: Amyloid PET Imaging Using AZD4694 and Unusually Brief Radiotracer Uptake and Scanning Periods

The Early Perfusion Image Is Useful to Support the Visual Interpretation of Brain Amyloid-PET With 18F-Flutemetamol in Borderline Cases

Sequential PET/diffusion-weighted Imaging in the Evaluation of Myocardial Perfusion and Viability in Coronary Artery Disease: a Preliminary Study

Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification

P1‐408: 18F‐FDG AND 18F‐AV45 POSITRON EMISSION TOMOGRAPHY IN ALZHEIMER'S DISEASE